ReviewWiener klinische Wochenschrift2019
["Diabesity"-Obesity and type 2 diabetes (Update 2019)].
Review in Wiener klinische Wochenschrift, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.
- Prevalence and associated factors of overweight and obesity among persons with type 2 diabetes in Africa: a systematic review and meta-analysis.Annals of medicine · 2023Pooled it
- Extraction, Purification, Structural Characteristics, Biological Activity and Application of Polysaccharides fromMolecules (Basel, Switzerland) · 2023Pooled it
- Diabetes knowledge, risk and severity perceptions, lifestyle behaviours and management barriers among Sub-Saharan African immigrants living in the UK: an ethnographic study.BMC public health · 2025Article
- Analysis of patients preferences in type 2 diabetes mellitus second-line drug treatment: A discrete choice experiment.PloS one · 2025Article
- Review
- Optimal obesity- and lipid-related indices for predicting type 2 diabetes in middle-aged and elderly Chinese.Scientific reports · 2024Article
- Cluster of Physical Inactivity and Other Risk Factors and Diabesity in Quilombol Adults.Arquivos brasileiros de cardiologia · 2024Article
- CT Quantitation and Prediction of the Risk of Type 2 Diabetes Mellitus in Non-Obese Patients with Pancreatic Fatty Infiltration.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024Article
- Association of dietary total antioxidant capacity with general and abdominal obesity in type 2 diabetes mellitus patients.PloS one · 2024Article
- [Overweight and obesity in adults: general principles of treatment and conservative management].Wiener klinische Wochenschrift · 2023Article
- Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Diabetology & metabolic syndrome · 2023Review
- Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts.Nature communications · 2023Article
- Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysis.EClinicalMedicine · 2023Article
- Gender-Specific Association of Handgrip Strength with Type 2 Diabetes Mellitus in Chinese Han Older Adults.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023Article
- Adipocyte dysfunction promotes lung inflammation and aberrant repair: a potential target of COPD.Frontiers in endocrinology · 2023Article
- Complex Association Among Diet Styles, Sleep Patterns, and Obesity in Patients with Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023Article
- Influence of Educational Level and Healthy Habits on the Prevalence of Diabesity in a Spanish Working Population.Nutrients · 2022Article
- Article
- Quantitative analysis of the risk of type 2 diabetes and fatty liver in non-obese individuals by computed tomography.Abdominal radiology (New York) · 2022Article
- [Prevalence of diabesity in the Spanish working population: influence of sociodemographic variables and tobacco consumption].Anales del sistema sanitario de Navarra · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For several years obesity and type 2 diabetes have been increasingly summarized under the name "diabesity". This is due to the fact that in most cases obesity precedes diabetes and is the most important risk factor for the worldwide increase of type 2 diabetes. The body mass index (BMI) is a very crude measure of body fatness in individuals. Even normal weight persons can have too much body fat in cases of a lack of muscle mass (sarcopenia), which is why additional measurements of waist circumference and body fatness, e. g. bioimpedance analysis (BIA), are recommended. Lifestyle management including nutrition modification and increase in physical activity are important measures for the prevention and treatment of diabetes. Regarding the treatment of type 2 diabetes, body weight is increasingly used as a secondary target parameter. The choice of anti-diabetic treatment and also concomitant treatment is increasingly influenced by body weight. The significance of anti-obesity medications in the treatment of type 2 diabetes will have to be clarified by future studies with body weight as the primary endpoint. Bariatric surgery is at present indicated with a BMI >35 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.